Stacey L. McDaniel

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.

Joseph P. Vacca, Bruce D. Dorsey, William A. Schleif et al. · Proceedings of the National Academy of Sciences · 1994 · 526 citations · Full text

Immunology, Cell Culture, Pharmacotherapy +19

L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor

Bruce D. Dorsey, Rhonda B. Levin, Stacey L. McDaniel et al. · Journal of Medicinal Chemistry · 1994 · 408 citations · Full text

Identification of MK-944a:  A Second Clinical Candidate from the Hydroxylaminepentanamide Isostere Series of HIV Protease Inhibitors

Bruce D. Dorsey, Colleen M. McDonough, Stacey L. McDaniel et al. · Journal of Medicinal Chemistry · 2000 · 55 citations · Full text

Immunology, Pharmacotherapy, Antiviral Drug +17

A practical synthesis of 5‐(chloromethyl)furo[2,3‐<i>b</i>]pyridine, a key intermediate for the HIV protease inhibitor, L‐754,394

M. Bhupathy, David A. Conlon, Kenneth M. Wells et al. · Journal of Heterocyclic Chemistry · 1995 · 33 citations

Medicinal Chemistry, Practical Synthesis, Key Intermediate +14

Time- and dose-dependent pharmacokinetics of L-754,394, an HIV protease inhibitor, in rats, dogs and monkeys.

Jiunn H. Lin, Masato Chiba, I W Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 26 citations